Medical marijuana profits soar while regulations lag

The cannabis industry borrows from pharma's marketing playbook but dodges pharmaceutical regulations. Could there be a crackdown?

December 21, 2023 Check out STAT+

Sponsored By

Eros Dervishi for STAT STAT+ | Medical marijuana companies are using pharma's sales tactics with little of the same scrutiny The cannabis industry borrows from pharma's marketing playbook but dodges pharmaceutical regulations. Could there be a crackdown? By Nicholas Florko Health data breaches hit an all-time high in 2023 At least 116 million individuals were impacted by large health data breaches reported to federal regulators this year. By Katie Palmer Obesity drugs' next tests, and rising threats: 3 chronic disease stories to watch While drugs like Wegovy and Zepbound made obesity a top topic in 2023, there are other chronic illnesses that are rising. By Isabella Cueto and Elaine Chen Caroline Yang for STAT STAT's most memorable photos of 2023 This year brought huge changes in medicine and science, and STAT's photos centered the people they impact: scientists, doctors, patients, and families. By Alissa Ambrose and Crystal Milner STAT+ | Drugs are still mostly tested in white men. Will the FDA change that next year? Congress gave the FDA more power to get companies to racially diversify clinical trials, and we'll soon see how the agency uses it. By John Wilkerson Opinion: Why haven't health care cost increases exceeded inflation? There's a very good reason Since 2010, the mindset of American physicians has changed, from ignoring costs to trying to cut them. It's working. By Ezekiel J. Emanuel Listen: 2023 in review, CEO report cards, and a look at the year ahead In our last episode of 2023, we look back on the biggest stories of the year and discuss the best and worst CEOs in the biotech industry. By Damian Garde and Allison DeAngelis and Adam Feuerstein STAT+ | Patent thickets and terminal disclaimers: How pharma blocks biosimilars from the marketplace A new study analyzes tactics used to manipulate the patent system — patent thickets and terminal disclaimers. By Ed Silverman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser